Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Common Ion Effect03:24

Common Ion Effect

46.0K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
46.0K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

250
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
250
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

534
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
534
Heat and Free Expansion01:24

Heat and Free Expansion

2.8K
The work done by a thermodynamic system depends not only on the initial and final states but also on the intermediate states—that is, on the path. Like work, when heat is added to a thermodynamic system, it undergoes a change of state, and the state attained depends on the path from the initial state to the final state. Consider an ideal gas cylinder fitted with a piston. When the cylinder is heated at a constant temperature, the gas molecules absorb energy and expand slowly in a...
2.8K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

244
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
244
Thermal Expansion01:22

Thermal Expansion

5.6K
The expansion of alcohol in a thermometer is one of many commonly encountered examples of thermal expansion, which is the change in size or volume of a given system as its temperature changes. The most visible example is the expansion of hot air. When air is heated, it expands and becomes less dense than the surrounding air, which then exerts an upward force on the hot air to, for example, make steam and smoke rise, and hot air balloons float. The same behavior happens in all liquids and gases,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced Near-Field Focusing via Interior Cavity and Nanogap Coupling in Disk-Cavity-Trench Nanostructures.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Multi-Ion Zeolite-Based Antimicrobial LDPE Films for Active Food Packaging: Ion Combinations and Performance in Real Food Systems.

Journal of food science·2026
Same author

Design and evaluation of an automated pediatric acute lymphoblastic leukemia registry from clinical data warehouses.

BMC medical informatics and decision making·2026
Same author

I<sup>2</sup>MoE: Interpretable Multimodal Interaction-aware Mixture-of-Experts.

Proceedings of machine learning research·2026
Same author

K-MIMIC: a nationwide Korean multi-institutional Multimodal intensive care dataset.

Korean journal of anesthesiology·2026
Same author

Glucose-mediated Maillard crosslinking of pea protein scaffolds to enhance mechanical properties and myoblast proliferation.

Food chemistry·2026

Related Experiment Video

Updated: Jan 20, 2026

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.0K

Expansion of EHR-Based Common Data Model (CDM).

Wona Choi1, Soo Jeong Ko1, Hyuck Jun Jung1

  • 1Department of Medical Informatics, College of Medicine, The Catholic University, Seoul, Republic of Korea.

Studies in Health Technology and Informatics
|August 24, 2019
PubMed
Summary

A new Common Data Model (CDM) was created using hospital electronic health records (EHR) to standardize Adverse Drug Reaction (ADR) data. This enables collaborative research and analysis across institutions with varying data structures.

Keywords:
DatabaseElectronic Health RecordsObservational Study

More Related Videos

Author Spotlight: Development of a Novel Finite Element Analysis Model for Improved Orthognathic Surgical Techniques
07:16

Author Spotlight: Development of a Novel Finite Element Analysis Model for Improved Orthognathic Surgical Techniques

Published on: October 20, 2023

1.8K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

15.2K

Related Experiment Videos

Last Updated: Jan 20, 2026

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.0K
Author Spotlight: Development of a Novel Finite Element Analysis Model for Improved Orthognathic Surgical Techniques
07:16

Author Spotlight: Development of a Novel Finite Element Analysis Model for Improved Orthognathic Surgical Techniques

Published on: October 20, 2023

1.8K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

15.2K

Area of Science:

  • Health Informatics
  • Pharmacovigilance
  • Data Science

Background:

  • Hospital electronic health records (EHR) contain valuable data on Adverse Drug Reactions (ADRs).
  • Existing data structures across institutions hinder collaborative ADR research and analysis.
  • A standardized approach is needed to integrate and compare ADR data effectively.

Purpose of the Study:

  • To develop and implement a Common Data Model (CDM) for hospital EHR data.
  • To facilitate the analysis and comparison of Adverse Drug Reactions (ADRs) across different healthcare organizations.
  • To establish a foundation for multi-institutional, simultaneous research on diverse data sources.

Main Methods:

  • Expansion and construction of a Common Data Model (CDM).
  • Utilizing hospital electronic health record (EHR) data.
  • Integration of data from external organizations with varying data structures.

Main Results:

  • A functional Common Data Model (CDM) was successfully developed and implemented.
  • The CDM enables standardized analysis and comparison of Adverse Drug Reactions (ADRs).
  • Facilitated integration of data from institutions with different data structures.

Conclusions:

  • The constructed Common Data Model (CDM) allows for joint research and analysis of Adverse Drug Reactions (ADRs).
  • This standardization provides a basis for conducting simultaneous research across multiple data sources.
  • The CDM is crucial for advancing collaborative pharmacovigilance efforts.